AI Article Synopsis

  • - The study explored how different dopaminergic drugs affect spontaneous motor activity in common marmosets that underwent bilateral brain infusion of 6-hydroxydopamine (6-OHDA), a chemical that can damage dopamine-producing neurons.
  • - Following drug treatments, it was found that the marmosets with 6-OHDA infusion showed varying responses: apomorphine caused a brief increase in activity, methamphetamine led to decreased activity, and L-3,4-dihydroxyphenylalanine resulted in increased activity without overstimulation.
  • - These findings suggest that using 6-OHDA-infused marmosets can be a useful model for studying dopaminergic drug effects in brains with dopamine

Article Abstract

The differential effects of dopaminergic drugs with different pharmacological profiles were investigated with respect to spontaneous motor activity in the common marmoset following pretreatment with a bilateral brain infusion of 6-hydroxydopamine (6-OHDA). Three marmosets received infusions of 6-OHDA (either 30 or 40 μg/side) into the bilateral dopamine-rich area running from the substantia nigra to the striatum. The motor activity of the 6-OHDA marmosets was compared with that of three intact marmosets. Following the administration of apomorphine (0.5 and 1 mg/kg, subcutaneously), the 6-OHDA group showed a tendency toward a brief increase in activity counts, suggesting denervation supersensitivity at the dopamine receptors. After the administration of methamphetamine (1 and 2 mg/kg, subcutaneously), the 6-OHDA group showed a significant decrease in activity counts, indicating limited dopamine release from the degenerated neurons. After the administration of L-3,4-dihydroxyphenylalanine (10 and 20 mg/kg, orally), the 6-OHDA group showed a significant increase in activity counts without hyperexcitation, consistent with the contribution of exogenous L-3,4-dihydroxyphenylalanine toward dopamine synthesis in the degenerated neurons. The present findings indicate that bilateral brain infusion of 6-OHDA in the marmoset may have preclinical utility as a primate model for investigating the behavioral properties of dopaminergic drugs in brains with dopaminergic neural deficits.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690296PMC
http://dx.doi.org/10.1097/FBP.0000000000000353DOI Listing

Publication Analysis

Top Keywords

dopaminergic drugs
12
motor activity
12
bilateral brain
12
brain infusion
12
6-ohda group
12
activity counts
12
differential effects
8
effects dopaminergic
8
spontaneous motor
8
activity common
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!